Comments on the refinement process of 4: Compound 4 crystallizes in the monoclinic space group C2/c with one organometallic P 2 complex, one Ag + cation and two halves of a [BF 4 ] -anion as well as two halves of a pyrimidine ligand in the asymmetric unit. The least squares refinement of 4 could be performed without encountering any problems.
Comments on the refinement process of 5:
Compound 5 crystallizes in the monoclinic space group P2 1 /c with one organometallic P 2 complex, two Ag + cations, one complete and two halves of a pyrimidine ligand and two [BF 4 ] -anions in the asymmetric unit. The least squares refinement could be performed without encountering any problems. However, some con-and restraints had to be applied during the refinement process. The following paragraph describes all measures in detail and has also been added to the supplied cif file under the reference '_refine_special_details'. One [BF 4 ] -anion is disordered over two close positions in a 41:59 ratio. During the refinement process, several restraints had to be applied. To be specific, The B-F distances and the F-F distances of both parts were equated by SADI restraints. The less occupied F atoms (41%) and both positions of the B atom were refined isotropically. ADPs of isotropic F atoms and both positions of the B atom were equated to their respective atom type by EADP. One ISOR restraint was applied to F8 (59%) to avoid a pronounced prolate ellipsoid. The ADPs of the five carbon atoms of one Cp ligand were equated by EADP. Free refinement lead otherwise to a pronounced oblate ellipsoid for C11.
